230 related articles for article (PubMed ID: 25659726)
1. Immunophenotyping for diagnosis and prognosis in MDS: ready for general application?
Cremers EM; Alhan C; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
Best Pract Res Clin Haematol; 2015 Mar; 28(1):14-21. PubMed ID: 25659726
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Mejstrikova E; Nováková M; Zecca M; Zwaan CM; Te Marvelde JG; Langerak AW; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH
Haematologica; 2015 Mar; 100(3):315-23. PubMed ID: 25425683
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.
Della Porta MG; Lanza F; Del Vecchio L;
Cytometry B Clin Cytom; 2011; 80(4):201-11. PubMed ID: 21674774
[TBL] [Abstract][Full Text] [Related]
4. MDS prognostic scoring systems – past, present, and future.
Jonas BA; Greenberg PL
Best Pract Res Clin Haematol; 2015 Mar; 28(1):3-13. PubMed ID: 25659725
[TBL] [Abstract][Full Text] [Related]
5. A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes.
Huang J; Lai P; Zhou M; Weng J; Lu Z; Du X
Clin Lab; 2012; 58(11-12):1241-51. PubMed ID: 23289195
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.
Xu F; Wu L; He Q; Zhang Z; Chang C; Li X
Intern Med J; 2012 Apr; 42(4):401-11. PubMed ID: 22032631
[TBL] [Abstract][Full Text] [Related]
7. [Role of flow cytometric immunophenotyping in diagnosis of myelodysplastic syndromes--review].
Zhang Y; Li X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1477-81. PubMed ID: 19099668
[TBL] [Abstract][Full Text] [Related]
8. Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML.
Blatt K; Herrmann H; Hoermann G; Willmann M; Cerny-Reiterer S; Sadovnik I; Herndlhofer S; Streubel B; Rabitsch W; Sperr WR; Mayerhofer M; Rülicke T; Valent P
Clin Cancer Res; 2014 Jul; 20(13):3589-602. PubMed ID: 24799522
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoring.
Oelschlaegel U; Westers TM; Mohr B; Kramer M; Parmentier S; Sockel K; Thiede C; Bornhäuser M; Ehninger G; van de Loosdrecht AA; Platzbecker U
Haematologica; 2015 Mar; 100(3):e93-6. PubMed ID: 25425689
[No Abstract] [Full Text] [Related]
10. Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes.
Xu F; Guo J; Wu LY; He Q; Zhang Z; Chang CK; Li X
Cytometry B Clin Cytom; 2013; 84(4):267-78. PubMed ID: 23554290
[TBL] [Abstract][Full Text] [Related]
11. Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasms.
Kern W; Bacher U; Schnittger S; Alpermann T; Haferlach C; Haferlach T
Cytometry B Clin Cytom; 2013 May; 84(3):194-7. PubMed ID: 23283847
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
[TBL] [Abstract][Full Text] [Related]
13. Establishment and validation of an updated diagnostic FCM scoring system based on pooled immunophenotyping in CD34+ blasts and its clinical significance for myelodysplastic syndromes.
Xu F; Li X; Chang CK; Guo J; Wu LY; He Q; Zhang Z; Zhu Y; Gu SC; Shi WH; Song LX; Su JY; Zhou LY; Zhang X; Wu D
PLoS One; 2014; 9(2):e88706. PubMed ID: 24558415
[TBL] [Abstract][Full Text] [Related]
14. [Application of flow cytometry in detecting dysplasia of myelodysplastic syndromes].
Li J; He GS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1069-72. PubMed ID: 23998614
[TBL] [Abstract][Full Text] [Related]
15. Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms.
Ossenkoppele GJ; van de Loosdrecht AA; Schuurhuis GJ
Br J Haematol; 2011 May; 153(4):421-36. PubMed ID: 21385170
[TBL] [Abstract][Full Text] [Related]
16. [Research advances in value of flow cytometric immunophenotyping in diagnosis and prognostic evaluation of myelodysplastic syndrome].
Lu D; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):785-90. PubMed ID: 23815941
[TBL] [Abstract][Full Text] [Related]
17. A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome.
Chung JW; Park CJ; Cha CH; Cho YU; Jang S; Chi HS; Seo EJ; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
Ann Clin Lab Sci; 2012; 42(3):271-80. PubMed ID: 22964615
[TBL] [Abstract][Full Text] [Related]
18. Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes.
Alhan C; Westers TM; van der Helm LH; Eeltink C; Huls G; Witte BI; Buchi F; Santini V; Ossenkoppele GJ; van de Loosdrecht AA
Cytometry B Clin Cytom; 2014 May; 86(3):207-15. PubMed ID: 24474614
[TBL] [Abstract][Full Text] [Related]
19. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes.
Verigou E; Lampropoulou P; Smyrni N; Kolliopoulou G; Sakellaropoulos G; Starakis I; Zikos P; Solomou E; Symeonidis A; Karakantza M
Cardiovasc Hematol Disord Drug Targets; 2015; 15(2):148-61. PubMed ID: 26126819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
